GATA2 and prostate cancer: Nevertheless, it can be concluded that GATA2 has restricted expression in benign prostate cells due to proteolytic degradation of GATA2-wt in contrast to the prostate cancer cell lines LNCaP and 22Rv1, and also in contrast to benign human kidney embryonal cells.